Adenosine kinase attenuates cardiomyocyte microtubule stabilization and protects against pressure overload-induced hypertrophy and LV dysfunction

被引:20
作者
Fassett, John [1 ]
Xu, Xin [4 ]
Kwak, Dongmin [2 ,3 ]
Zhu, Guangshuo [5 ]
Fassett, Erin K. [1 ]
Zhang, Ping [2 ,3 ]
Wang, Huan [2 ,3 ]
Mayer, Bernd [1 ]
Bache, Robert J. [1 ]
Chen, Yingjie [1 ]
机构
[1] Karl Franzens Univ Graz, Dept Pharmacol & Toxicol, Humboldtstr 46, A-8010 Graz, Austria
[2] Univ Minnesota, Cardiovasc Div, Minneapolis, MN 55455 USA
[3] Univ Minnesota, Lillehei Heart Inst, Minneapolis, MN 55455 USA
[4] Shanghai Univ Sport, Dept Exercise Rehabil, Shanghai 200438, Peoples R China
[5] Johns Hopkins Univ, Sch Med, Dept Med, Div Cardiol, Baltimore, MD 21205 USA
关键词
Adenosine; Adenosine kinase; Microtubules; Detyrosinated tubulin; Cardiac hypertrophy; CONTRACTILE DYSFUNCTION; CARDIAC-HYPERTROPHY; CYTOSKELETAL ROLE; HEART; INHIBITION; TUBULIN; TRAFFICKING;
D O I
10.1016/j.yjmcc.2019.03.015
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Adenosine exerts numerous protective actions in the heart, including attenuation of cardiac hypertrophy. Adenosine kinase (ADK) converts adenosine to adenosine monophosphate (AMP) and is the major route of myocardial adenosine metabolism, however, the impact of ADK activity on cardiac structure and function is unknown. To examine the role of ADK in cardiac homeostasis and adaptation to stress, conditional cardiomyocyte specific ADK knockout mice (cADK(-/-)) were produced using the MerCreMer-lox-P system. Within 4 weeks of ADK disruption, cADK(-/-) mice developed spontaneous hypertrophy and increased beta-Myosin Heavy Chain expression without observable LV dysfunction. In response to 6 weeks moderate left ventricular pressure overload (transverse aortic constriction;TAC), wild type mice (WT) exhibited similar to 60% increase in ventricular ADK expression and developed LV hypertrophy with preserved LV function. In contrast, cADK(-/-) mice exhibited significantly greater LV hypertrophy and cardiac stress marker expression (atrial natrurietic peptide and beta-Myosin Heavy Chain), LV dilation, reduced LV ejection fraction and increased pulmonary congestion. ADK disruption did not decrease protein methylation, inhibit AMPK, or worsen fibrosis, but was associated with persistently elevated mTORC1 and p44/42 ERK MAP kinase signaling and a striking increase in microtubule (MT) stabilization/detyrosination. In neonatal cardiomyocytes exposed to hypertrophic stress, 2-chloroadenosine (CADO) or adenosine treatment suppressed MT detyrosination, which was reversed by ADK inhibition with iodotubercidin or ABT-702. Conversely, adenoviral over-expression of ADK augmented CADO destabilization of MTs and potentiated CADO attenuation of cardiomyocyte hypertrophy. Together, these findings indicate a novel adenosine receptor-independent role for ADK-mediated adenosine metabolism in cardiomyocyte microtubule dynamics and protection against maladaptive hypertrophy.
引用
收藏
页码:49 / 58
页数:10
相关论文
共 50 条
  • [11] 2-Methoxyestradiol protects against pressure overload-induced left ventricular hypertrophy
    Maayah, Zaid H.
    Levasseur, Jody
    Piragasam, Ramanaguru Siva
    Abdelhamid, Ghada
    Dyck, Jason R. B.
    Fahlman, Richard P.
    Siraki, Arno G.
    El-Kadi, Ayman O. S.
    SCIENTIFIC REPORTS, 2018, 8
  • [12] Angiotensin-Converting Enzyme 3 (ACE3) Protects Against Pressure Overload-Induced Cardiac Hypertrophy
    Yu, Chang-Jiang
    Tang, Liang-Liang
    Liang, Chen
    Chen, Xiao
    Song, Shu-Ying
    Ding, Xiao-Qing
    Zhang, Kun-Yu
    Song, Bin-Lin
    Zhao, Dan
    Zhu, Xue-Yong
    Li, Hong-Liang
    Zhang, Zhi-Ren
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2016, 5 (02): : 1 - 15
  • [13] Puerarin attenuates pressure overload-induced cardiac hypertrophy
    Yuan, Yuan
    Zong, Jing
    Zhou, Heng
    Bian, Zhou-Yan
    Deng, Wei
    Dai, Jia
    Gan, Hua-Wen
    Yang, Zheng
    Li, Hongliang
    Tang, Qi-Zhu
    JOURNAL OF CARDIOLOGY, 2014, 63 (1-2) : 73 - 81
  • [14] MicroRNA-27 attenuates pressure overload-Induced cardiac hypertrophy and dysfunction by targeting galectin-3
    Zhang, Meiqi
    Cheng, Kang
    Chen, Huan
    Tu, Jianfeng
    Shen, Ye
    Pang, Lingxiao
    Wu, Weihua
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2020, 689
  • [15] Atorvastatin Attenuates Pressure Overload-induced Cardiac Hypertrophy and Dysfunction Through Enhanced Autophagy
    Zhao, Zhuo
    Wang, Wei
    Wang, Hua-Ting
    Geng, Qing-Xin
    Zhao, Di
    Su, Guohai
    CIRCULATION RESEARCH, 2015, 117
  • [16] miR-30a downregulation aggravates pressure overload-induced cardiomyocyte hypertrophy
    Xuesong Yin
    Chenghai Peng
    Wenhu Ning
    Chunyan Li
    Zhongqiao Ren
    Jihong Zhang
    Han Gao
    Kan Zhao
    Molecular and Cellular Biochemistry, 2013, 379 : 1 - 6
  • [17] Cucurbitacin B Protects Against Pressure Overload Induced Cardiac Hypertrophy
    Xiao, Yang
    Yang, Zheng
    Wu, Qing-Qing
    Jiang, Xiao-Han
    Yuan, Yuan
    Chang, Wei
    Bian, Zhou Yan
    Zhu, Jin Xiu
    Tang, Qi-Zhu
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2017, 118 (11) : 3899 - 3910
  • [18] Sanggenon C protects against pressure overload-induced cardiac hypertrophy via the calcineurin/NFAT2 pathway
    Xiao, Lili
    Gu, Yulei
    Gao, Lu
    Shangguan, Jiahong
    Chen, Yang
    Zhang, Yanzhou
    Li, Ling
    MOLECULAR MEDICINE REPORTS, 2017, 16 (04) : 5338 - 5346
  • [19] Growth/differentiation factor 1 alleviates pressure overload-induced cardiac hypertrophy and dysfunction
    Zhang, Yan
    Zhang, Xiao-Fei
    Gao, Lu
    Liu, Yu
    Jiang, Ding-Sheng
    Chen, Ke
    Yang, Qinglin
    Fan, Guo-Chang
    Zhang, Xiao-Dong
    Huang, Congxin
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2014, 1842 (02): : 232 - 244
  • [20] Crucial Role of Rho-Kinase in Pressure Overload-Induced Right Ventricular Hypertrophy and Dysfunction in Mice
    Ikeda, Shohei
    Satoh, Kimio
    Kikuchi, Nobuhiro
    Miyata, Satoshi
    Suzuki, Kota
    Omura, Junichi
    Shimizu, Toru
    Kobayashi, Kenta
    Kobayashi, Kazuto
    Fukumoto, Yoshihiro
    Sakata, Yasuhiko
    Shimokawa, Hiroaki
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2014, 34 (06) : 1260 - 1271